AXP

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.02%

Status

scored

Maintain Hold at $308 with stop at $295 pending Q3 2026 earnings binary catalyst in 2-3 weeks. Pre-committed three-scenario framework (Beat-and-raise → Overweight $329-$340; Meet-with-soft-guide → Hold; Disappoints-guide-down → Underweight 15-20% trim) ensures mechanical post-print execution without emotional bias. Death cross, sub-40 RSI, and three overhead MAs remain in effect, making adds premature while the buyback floor at $295-$302 absorbs downside.

Outcome

✗

Return

+1.27%

Status

scored

Maintain AXP at half-benchmark weight (~2-3% of portfolio) with a tightened $295 stop for worst-execution protection, neither adding ahead of Q3 earnings due to bearish technical setup (death cross + sub-40 RSI + three overhead MAs) nor trimming given intact fundamentals (34.4% ROE, Berkshire anchor, sub-3% charge-offs). Pre-committed three mechanical Q3 earnings scenarios—Beat-and-raise triggers Overweight upgrade to $329-$340, Meet-with-soft-guide maintains Hold, and Disappoints-guide-down requires 15-20% trim to 1% portfolio with stop tightened to $292—with binary resolution expected mid-to-late October.

Outcome

✓

Return

-0.10%

Status

scored

Maintain AXP at neutral weight with rating HOLD as both bull and bear cases are partially correct but overreach in magnitude; tightened stop at $295 above lower Bollinger $294.05 to avoid stop-hunt risk at $290 round number, with pre-committed Q3 earnings scenarios (beat-and-raise/meet-with-soft-guide/disappoints-guide-down) as the binary resolution path.

Outcome

✓

Return

+0.17%

Status

scored

Maintain AXP at current levels (~302) with Active Hold discipline—tighten stop to $295 to avoid stop-hunt at lower Bollinger $294.12, pre-commit to three Q3 scenarios (beat-and-raise upgrades to OW at $329-$340, meet-with-soft-guide maintains Hold, disappoints-guide-down downgrades to UW with 15-20% trim), and add relative-strength exit trigger (-150bps vs SPY over 5 trading days). No trimming (four prior trim failures dispositive) and no adding (9/30 death cross + sub-40 RSI + overhead MAs all confirmed).

Outcome

✓

Return

+0.41%

Status

scored

Maintain AXP at current levels (~302) with active HOLD discipline—do not trim or add—while tightening the invalidation stop to $295 and adding a relative-strength exit trigger (underperform SPY by >150bps over 5 days). Pre-commit to three Q3 scenarios: Overweight reassessment if beat-and-raise closes above $310, maintain Hold on meet-with-soft-guide, and Underweight trim on disappoints-guide-down. The binding constraints are the prior trim failures (9/21: -2.7% alpha, 9/28: -0.1%, 9/29: -0.2%, 9/30: -0.1%) and confirmed technical deterioration (death cross, RSI 32.81, three overhead MAs).

Outcome

✓

Return

+0.23%

Status

scored

Analysts maintain AXP at $302 with a HOLD rating as risk-reward is balanced rather than asymmetric ahead of the mid-October Q3 2026 earnings catalyst. The 9/30 technical setup (death cross + sub-40 RSI + three overhead MAs) argues against adding, while the 9/21 trim pattern history (-2.7%/-0.1%/-0.2% alpha) argues against reducing, with the hard stop set at $289 (March support) and tactical add only on close >$307.46 with RSI >40 and volume ≥4M shares.

Outcome

–

Return

-0.66%

Status

scored

Analyst upgrades AXP to Overweight from Hold/Underweight, executing 50% position at market ($304) while deferring the remaining 50% until after Q3 earnings mid-October. Hard stop set at $289 (regime change) with softer reduction at $295 on deteriorating volume; post-Q3 playbook calls for full target addition on clean print (charge-offs <3%, spend >9% TTM, NII higher) or reassessment to Hold on credit deterioration signals.

Outcome

–

Return

-0.43%

Status

scored

Underweight rating on AXP with a magnitude-calibrated trim of 25–30% at current levels ($305–311) to capture directional edge without crystallizing loss ahead of the Q3 earnings binary catalyst; residual 50–60% position protected via cost-neutral collar (sell $325 call/buy $290 put through Q3 print), with hard invalidation stop at $295 close on volume ≥4M shares.

Outcome

–

Return

-0.30%

Status

scored

Tactical trim of 15-25% of AXP position at $306 justified by the 9/25 binding reflection's progressive alpha compression directive (degrading from +1.9% to -0.1% across consecutive Holds), with execution biased toward the higher end (20-25%) only if weakness below $304 confirms distribution acceleration. The trade maintains a hard stop at $290 on the residual position while preserving capacity for further reduction on any relief rally toward $320-325, with re-evaluation scheduled at Q3 2026 earnings as the binary catalyst on net charge-off trajectory.

Outcome

✓

Return

-0.83%

Status

scored

Maintain neutral AXP exposure with HOLD rating as the disciplined-correct call. Technical signals (death cross, expanding negative MACD, $23 price/MA divergence) warrant patience, while franchise fundamentals (34% ROE, $8B annual capital return, Berkshire anchor) prevent downgrade. Key execution parameters: $300.05 close-on-volume invalidation stop and $290.97 structural break floor, with primary re-engagement at $334 death-cross reclaim on ≥4M volume or secondary at $313 with MACD contraction and RSI >40. Binary catalyst is Q3 2026 earnings in late October.

Outcome

✓

Return

+1.06%

Status

scored

Maintain AXP exposure with $290.97 as the structural invalidation stop; Q3 2026 earnings (late October) serve as the binary catalyst for re-evaluation. Downgrade triggers include charge-off rate increase >30bps QoQ, cardmember spending deceleration below 9%, NIM compression, close below $290.97, or Berkshire 13F trim. Upgrade to tactical add requires either a clean Q3 print with benign metrics, or price reclaiming $334 on volume ≥4M shares.

Outcome

✓

Return

+1.23%

Status

scored

Maintain AXP at current position with zero trim, as the 9/21 binding reflection prohibits premature technical trimming on a Berkshire-anchored, 34.4% ROE compounder with active buybacks that has produced negative alpha in two consecutive Underweight calls (9/18: -0.9% alpha; 9/21: -2.7% alpha). A tight $290.55 close-on-volume stop defines the structural invalidation level, with a binary re-evaluation catalyst at Q3 2026 earnings (late October) where charge-off rate, cardmember spend, and NIM commentary will determine whether the fundamental bar for trimming has been crossed.

Outcome

✓

Return

-1.02%

Status

scored

Maintain existing AXP exposure without adding at ~$305, as the aggressive BUY is rejected due to confirmed death cross with expanding MACD ahead of an unresolved Q3 earnings catalyst. The $290.97 stop (52-week low) serves as thesis invalidation, while a daily close above $335.16 on volume >4M shares would confirm medium-term trend reversal and warrant staged re-engagement. Q3 2026 earnings in late October is the binary catalyst—a clean print could unlock $345-365 re-rating, while a credit-cost spike could compress toward $275-285.

Outcome

✓

Return

-2.72%

Status

scored

Trim 25-30% of AXP allocation in scaled execution: ~10% at current levels ($311-313), 10-15% on any relief rally into $318-322, reserving 5-10% as dry powder for either re-engagement on confirmed reversal or further trim if $291 invalidation floor breaks. Replace the incoherent $342 stop with $336 close on volume >4M shares as re-engagement trigger and $291 close on volume as structural thesis invalidation. The 3-6 month time horizon targets Q3 2026 earnings late October as the binary validation catalyst, with Underweight rating justified by three aligned bearish technical signals and the Sep 16 rejection of raised guidance on 4.6M shares of institutional volume.

Outcome

–

Return

+0.65%

Status

scored

Trim 50% of AXP allocation at current levels ($311-315), with the $320-326 zone reserved for incremental sizing only if a relief bounce materializes. Hard stop at $328 on closing basis invalidates the trade thesis if price reclaims the 20-day MA. Rating is Underweight because AXP's franchise guardrails (34.4% ROE, $5B+ buyback execution, Berkshire anchor, 8% Polymarket recession probability) prohibit full exit, but the 50% trim reflects the 9/17 lesson that underweight conviction must be sized to the edge, not to franchise-quality comfort. The 30-60 day catalyst window is Q3 2026 earnings (late October).

Outcome

–

Return

+0.13%

Status

scored

AXP warrants a 40-50% trim (leaning toward 50%) given confirmed technical breakdown—price below all major MAs, expanding negative MACD histogram at -1.35, and close below lower Bollinger Band—combined with stretched 15.5x forward P/E valuation requiring 22% EPS growth against an 11% trajectory. The trade preserves Q3 earnings optionality (late October) and rejects short exposure due to 34.4% ROE franchise quality and Berkshire anchor, while rotating proceeds into less-loved quality compounders with cleaner technical structures and lower credit-cycle exposure.

Outcome

✓

Return

-0.40%

Status

scored

Hold AXP at $312 as the 34.4% ROE franchise with $5B+ annual buybacks has not broken its structural guardrails, but three bearish technical signals (price below all SMAs, MACD accelerating negative at -0.96, lower Bollinger collapsing) combined with sub-1:1 risk/reward (0.74 to $329) prohibit new entry. Existing positions should be maintained with a trailing stop at $289 (March swing low), with decisive re-evaluation after Q3 earnings late October.

Outcome

✓

Return

-3.70%

Status

scored

Reduce AXP by 40-50% from current levels, trimming into rallies at the $335-339 resistance confluence rather than initiating fresh shorts at the current $324.43 where risk/reward is unfavorable; re-engage on a close above $340.74. This modest Underweight acknowledges 34.4% ROE and $2.97B quarterly buybacks but finds the alignment of three bearish technical signals—price below all moving averages, MACD at -4.04, and zero equity risk premium—combined with a 5-7 week catalyst window into Q3 2026 earnings, warrants trim-not-hold positioning.

Outcome

✓

Return

-1.02%

Status

scored

Maintain AXP at benchmark weight with Hold rating due to binding 9/10 reflection, which prohibits selling a 34.4% ROE franchise with active buybacks at a lower-Bollinger touch without confirmed structural break. Explicit re-evaluation triggers set at $339.50 close on volume (upgrade to Overweight) and $319 break on volume (downgrade to Underweight at 50% benchmark). Q3 2026 earnings in late October serves as primary validation catalyst.

Outcome

✓

Return

+0.95%

Status

scored

Overweight rating on AXP reflects a 34.4% ROE franchise compounding EPS at ~16% CAGR with PEG 1.30, where the fundamental quality outweighs bearish technicals. Execute with 0.5% starter position, $305 stop (not $290), and confirmation-gated scaling rather than pre-committed layering into weakness.

Outcome

✗

Return

+1.24%

Status

scored

Three of three analyst types converge on Underweight for AXP with 75% benchmark weight as the calibrated sizing—underscoring directional conviction that exceeds mere risk management. The core thesis: sell into the relief rally at $327–$330 resistance rather than the lower-Bollinger print at $320.71, with re-entry tranches in the $280–$300 zone; hard stop and re-engagement gate at $340.40 close above the falling 50 SMA; Q3 2026 earnings in late October as primary binary catalyst.

Outcome

–

Return

-0.34%

Status

scored

Reduce AXP to 40-50% of full target weight (a 50-60% trim from current position), with sizing leaning toward the aggressive end of the range per the 9/8 AXP reflection lesson. Set the re-entry trigger at $340.74 (close above the falling 50 SMA), not the contested $335.63 level that all three analysts flagged as too tight. Q3 2026 earnings in late October serves as the binary validation catalyst for re-engaging above the trimmed level.

Outcome

✓

Return

-1.32%

Status

scored

Reduce AXP to 50-60% of full target weight (40-50% trim) based on the binding 9/03 lesson that passive Hold when binary triggers don't fire and the catalyst is 45-60 days out costs more than Underweight, with three consecutive Hold calls producing -2.9% alpha drag versus +0.5% on the 9/04 Underweight. Re-engagement gates are set at $332.05 (upgrade to Hold) and $348.99 (upgrade to Overweight) with hard stop at $323.92; post-FOMC execution is asymmetric—if Fed hikes and AXP flushes to $307, the trim becomes alpha capture, and if Fed holds and price reclaims $332.05, the trimmed tranche gets re-engaged.

Outcome

✗

Return

-0.02%

Status

scored

AXP is rated Underweight at 50-60% of full target weight (a 40-50% trim from current exposure), with a hard stop at $323.92 and re-engagement gates at $335.78. The rating reflects broken medium-term technicals (death cross formed, below all MAs, MACD negative) alongside an intact structural thesis (34.4% ROE, Berkshire anchor, accelerating capital return), calibrated to the 45-60 day catalyst window before Q3 2026 earnings in late October.

Outcome

✗

Return

-1.11%

Status

scored

Maintain AXP at current exposure without adding or trimming, as the aggressive Buy case fails on four grounds: ATR compression is non-directional, a death cross is imminent with mechanical flow headwinds, the 3:1 risk/reward math is unrealistic, and the multiple expansion thesis lacks specific evidence. Pure Hold without monitoring is also inadequate per the 9/02 binding reflection—the position must be held actively with defined triggers rather than passively. Buy trigger requires close above $332.05 with positive MACD histogram AND volume ≥3M shares; sell trigger is confirmed close below $325.65 on volume ≥3M shares.

Outcome

✓

Return

-0.05%

Status

scored

Maintain AXP at HOLD with hard stop at $326; do not add at $329.98—await either a confirmed close above $342 with positive MACD histogram or a flush to $310-315 with oversold RSI and constructive MACD divergence. Reassess to UNDERWEIGHT if Q3 13F (mid-November) confirms Berkshire trimming AXP; reassess to OVERWEIGHT on three-legged technical confirmation ahead of Q3 2026 earnings catalyst in late October.

Outcome

✗

Return

+1.79%

Status

scored

American Express is downgraded to Underweight with a target of $318, recommending a 60-75% target weight (25-40% reduction from full conviction) with a hard stop at $326. The bear case targets $318 (July low) and $307 (February capitulation low), while upside re-engagement requires $336 reclaim with MACD contraction and volume >2x, or $358 for full Overweight upgrade. Q3 2026 earnings in late October serve as the primary binary validation catalyst.

Outcome

✗

Return

-1.81%

Status

scored

Three analysts unanimously recommend HOLD for AXP based on a binding reflection chain that mandates full target weight rather than intermediate trims. The 34.4% ROE franchise is structurally sound, but technical damage (below all MAs, MACD negative) and 640% YoY net debt expansion warrant a wait-and-see approach until Q3 2026 earnings or a confirmed technical trigger (close >$342.38 with volume >3M and positive MACD histogram).

Outcome

✓

Return

-0.91%

Status

scored

Hold AXP at full target weight with structural stop at $326, rejecting Buy (timing thesis falsified by binding reflection chain) and Underweight (no fundamental deterioration justifies exit). The $329 price target reflects lower Bollinger/200 SMA midpoint with upside to $342-349 on confirmation. Q3 2026 earnings in late October is the primary validation catalyst; upgrade to Overweight requires three-legged confirmation: close above $336.54 on volume >2x 30-day average, positive MACD histogram crossover, and 2-3 session hold above 200 SMA.

Outcome

✓

Return

-0.29%

Status

scored

Hold AXP at full target weight per binding Aug 25-26 reflection chain rejecting intermediate trim as friction-producing without demonstrated edge. The consensus-defensible rating is supported by four of five analysts; the Aggressive Analyst's coiled-spring Buy case is rejected for being technically backwards given price below four major moving averages, accelerating negative MACD, and RSI at 44. Price target is $329 anchored to lower Bollinger band/200 SMA midpoint with $326 hard stop and Q3 2026 earnings (late October) as the primary validation catalyst.

Outcome

✓

Return

-0.59%

Status

scored

Maintain AXP at 80-90% of target weight (Hold rating), with the 3.5% capital return yield providing a structural floor through sideways resolution. New capital deployment is gated on cleaner setups: confirmed breakout above $358 with volume and positive MACD histogram, or pullback to $310-320 offering 4:1 risk/reward. Hard stop at $326 close on volume (July 24 capitulation low), with $330.32 as early warning for 50% reduction. Q3 2026 earnings mid-October is the primary validation catalyst.

Outcome

✓

Return

+0.06%

Status

scored

Maintain AXP at 70-75% target weight with a 25-30% trim from full conviction, reflecting the sideways-with-negative-drift base case. Hard stop at $326 with $330.32 early warning trigger; new capital deployment gated on confirmed breakout above $349.10 with volume >2x average and positive MACD. Q3 2026 earnings (mid-October) is the primary validation catalyst, with the provision for credit losses as the key tell.

Outcome

✓

Return

-0.41%

Status

scored

Maintain AXP at 80-90% of target weight with a modest 10-20% trim over 5-10 trading sessions in the $337-$342 range, as the Aug 21 binding reflection explicitly falsified an Underweight template on this exact pattern (coil on 30%+ ROE franchise with Berkshire anchor, no realized fundamental deterioration). Hold rather than Underweight or Sell because two consecutive prior Underweight calls produced positive alpha (+1.1% and +0.7%), and the technical coil signals on this franchise-quality name have been present for weeks without breakdown. Re-engagement to Overweight requires close above $342.50 with positive MACD and RSI reclaim 55+, or $354.47 reclaim with positive MACD histogram and volume above 3M shares.

Outcome

–

Return

+0.40%

Status

scored

Trim AXP to 65-75% of target weight (from 100%) given a confirmed downtrend with unanimous lower-high structure, expanding negative MACD, and price below all three major moving averages, but avoid full Sell given the stock's 34.4% ROE, 16% EPS CAGR, all-time-high Q2 2026 EPS, and widening moat. Execute the trim at current market ~$336 using limit orders rather than waiting for the $342-345 bounce zone, with a hard stop at $326.

Outcome

✗

Return

+1.46%

Status

scored

AXP is rated Underweight with target weight reduced to 50-60% per binding Aug 14 and Aug 19 reflections requiring defensive tilt in this negative-MACD coiled setup; hard stop at $326.17 (July 24 capitulation low) with re-engagement to Overweight requiring close above $354.47 with positive MACD histogram and volume >3M shares. The conservative analyst's $328 stop is rejected as inside 1.4x ATR noise, and the aggressive analyst's "Hold with bias to add" is rejected as pattern-inconsistent; Q3 2026 earnings (late October) is the primary validation catalyst.

Outcome

✓

Return

-2.57%

Status

scored

Trim AXP to 50-60% of high-conviction weight (within the binding 50-70% range) with hard stop at $326, rejecting the $332 stop as too tight in elevated-vol environment. The aggressive analyst correctly identifies 10-12% downside vs. ~6% upside asymmetry, but the conservative analyst correctly flags the hostile macro backdrop (oil +36% YTD, Hormuz closure, 86% no-cut probability). Underweight preserves franchise exposure (34% ROE, Berkshire anchor, B2M virtual cards, ~$30B loyalty value) for relief-rally scenarios while freeing dry powder. Re-entry requires three-legged confirmation: MACD-positive, 50 SMA reclaimed for ≥5 sessions, AND Q3 2026 earnings print showing neutral-to-improving credit metrics.

Outcome

✓

Return

+0.41%

Status

scored

Maintain AXP at 50-70% of target weight per the binding Aug 17 and Aug 14 reflections, which specify this tilt once the negative-MACD coiled setup resolves bearishly. Reject the trader's $330 entry/$328.81 stop as pattern-counter behavior—the binding prior lesson was explicit that a precise tilt response to this recurring pattern overrides a well-structured but pattern-counter plan. Hard stop is redefined to a close below $326.17 on volume, with full exit consideration below $320 on rising volume; re-engagement to Overweight requires three-legged confirmation: close above $354.47 with positive MACD histogram AND volume exceeding 3M shares.

Outcome

✓

Return

+0.69%

Status

scored

Hold American Express at 65-75% of target weight as the negative-MACD coiled setup has already resolved bearishly, confirmed by price breaking below all three moving averages for the first time in the consolidation with MACD line crossing below zero. Re-engagement to Overweight requires either a close above $354.47 with positive MACD histogram and volume exceeding 3M shares, or a successful retest of the $319-328 support cluster producing a bullish reversal candle on above-average volume.

Outcome

✗

Return

-1.83%

Status

scored

Maintain AXP at 75-90% of target weight (slight underweight) given the coiled technical setup with negative MACD and balance sheet expansion ($1.87B → $13.88B net debt). Add 25-50% tranche only on confirmed close above $354.47 with positive MACD histogram and volume >3M shares. Hard stop at $337.75 (200 SMA) with Q3 2026 earnings (late October) as the primary validation catalyst, with provision for credit losses being the key metric to watch.

Outcome

✓

Return

-0.34%

Status

scored

Maintain AXP at current weight with Hold rating as four consecutive tactical calls produced ~zero alpha in this range, and directional aggression is discouraged until Q3 2026 earnings (late October) validates the bull/bear credit cycle debate. Hard stop at $338.50 (50 SMA) triggers 25-50% trim on volume breach; full exit considered only on close below lower Bollinger Band at $327.72. Upside re-engagement requires simultaneous close above $356.53 on >3M volume with MACD resetting above zero. Hedge via $340 puts (3-6 month) at 2-3% of position value against the technical fragility and credit tail risk.

Outcome

✓

Return

-0.12%

Status

scored

Reduce AXP exposure with a 50% trim at $344, capping residual at 2% of portfolio, with a $355 stop to define risk — do not initiate new positions given an unfavorable risk/reward at current levels with $11 of risk versus $16-26 of upside on a confirmed breakout to $360-370 (1.4:1 to 2.4:1 ratio) and elevated credit-cycle tail risk. Q3 2026 earnings in October is the validation catalyst, with re-engagement triggers set at a confirmed close above $350 with positive MACD histogram (add back to ~3%) or revisit at $310-315 on credit-cycle deterioration.

Outcome

✓

Return

+0.96%

Status

scored

Maintain AXP at neutral weight given symmetric risk/reward with 13.7% upside to 52-week high ($387.49) versus 14.6% downside to 52-week low ($290.97); price at $340.81 sits above 50/200 SMA but MACD has been negative for 12 consecutive sessions with histogram widening, suggesting a coiled consolidation rather than directional move. The $325 stop loss at the lower Bollinger Band (~2x ATR of $7.51) is maintained over the Conservative analyst's suggested $333 level to avoid whipsaw from normal volatility, with re-engagement triggers at $348.50 close with volume and positive MACD (bullish) or $325 close with volume (bearish exit).

Outcome

–

Return

+0.58%

Status

scored

Trim 25-30% of AXP to 1.5% portfolio weight using phased execution—15% immediately at $338-340 and the remaining 10-15% on a confirmed break above $344.45 with volume—while maintaining a hard $335 stop-loss; rated Underweight due to asymmetric risk/reward favoring bears, confirmed momentum deterioration across MACD and moving averages, and tax rate normalization headwind, with Q3 2026 earnings serving as the validation catalyst.

Outcome

✓

Return

-0.60%

Status

scored

Reduce AXP to ≤1.5% of portfolio weight (below benchmark 2-3%) by trimming at current levels around $340-341 rather than attempting to time a bounce to higher levels. Re-engage with a position increase to ~2% on a sustained close above $364 with volume, or close entirely on a breakdown below $326 with volume. Q3 2026 earnings serves as the key catalyst for thesis re-evaluation, with Visa/MA relative performance and Berkshire 13F filings as cross-signals to monitor.